SCPHARMACEUTICALS

ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two-component delivery system suitable for patient self-administration. In February 2013 scPharmaceuticals was formed to continue the groundbreaking work of SpringLeaf Therapeutics, a Boston area company that started in 2007. scPharmaceuticals targets the untapped opportunity of treating patients with serious medical conditions with a convenient safe and comfortable subcutaneous administration of a drug. This is therapeutically equivalent to intravenous administration while avoiding the cost, burden, and risks associated with intravenous administration.